Skip to content
Search the site

Clinical trial NCT06778564

Status: RecruitingPhase 3Latest change: Source: ClinicalTrials.gov

What's on this page?

Information in the record

Original title: Stratification and Treatment in Early Psychosis Study - ENHANCE

Record number
NCT06778564
Status
Recruiting
Type and phase
Clinical trial, phase 3
Participants
Target: 250
Condition (as registered)
Psychosis, First Episode Psychosis, Psychotic Disorders, Psychotic Episode
Countries
Austria, Germany, Greece, Israel, Italy, Netherlands, Spain, Switzerland, United Kingdom
Topic in the guide
Schizophrenia

Timeline

According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.

  • Start: October 5, 2026
  • End of data collection for primary results: February 2028 (expected)
  • Trial completion: February 2029 (expected)

History

We check the record every day; here are the changes we have seen since we started tracking it, newest first.

  • : Added to tracking. Status: Recruiting.

Results

No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.

All ongoing trials · Schizophrenia: ongoing trials · Thinking of taking part? Which specialist to see